Allarity Therapeutics (NASDAQ:ALLR) Board Announces Stock Repurchase Program
Allarity Therapeutics (NASDAQ:ALLR – Get Free Report) announced that its board has authorized a share repurchase plan on Monday, March 3rd, RTT News reports. The company plans to buyback $5.00 million in shares. This buyback authorization authorizes the company to reacquire up to 128.1% of its shares through open market purchases. Shares buyback plans are […]
